News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
612,014 Results
Type
Article (48640)
Company Profile (206)
Press Release (563168)
Section
Business (171050)
Career Advice (3018)
Deals (31261)
Drug Delivery (99)
Drug Development (78098)
Employer Resources (170)
FDA (14847)
Job Trends (14145)
News (301617)
Policy (29885)
Tag
Academia (2756)
Alliances (43658)
Alzheimer's disease (1296)
Approvals (14778)
Artificial intelligence (138)
Bankruptcy (264)
Best Places to Work (11435)
Biotechnology (162)
Breast cancer (126)
Cancer (1137)
Cardiovascular disease (100)
Career advice (2535)
Cell therapy (242)
Clinical research (61649)
Collaboration (395)
Compensation (164)
COVID-19 (2664)
C-suite (90)
Data (1112)
Diabetes (156)
Diagnostics (6259)
Earnings (69056)
Employer resources (150)
Events (94411)
Executive appointments (276)
FDA (15363)
Funding (341)
Gene therapy (189)
GLP-1 (625)
Government (4514)
Healthcare (18449)
Infectious disease (2751)
Inflammatory bowel disease (116)
Interviews (542)
IPO (15503)
Job creations (3090)
Job search strategy (2103)
Layoffs (415)
Legal (6410)
Lung cancer (187)
Manufacturing (176)
Medical device (12496)
Medtech (12500)
Mergers & acquisitions (15884)
Metabolic disorders (421)
Neuroscience (1578)
NextGen Class of 2024 (6409)
Non-profit (4480)
Northern California (1397)
Obesity (234)
Opinion (236)
Patents (106)
People (45737)
Phase I (19226)
Phase II (27148)
Phase III (20580)
Pipeline (455)
Postmarket research (2353)
Preclinical (8171)
Radiopharmaceuticals (255)
Rare diseases (231)
Real estate (5181)
Regulatory (20276)
Research institute (2479)
Resumes & cover letters (522)
Southern California (1256)
Startups (3161)
United States (12737)
Vaccines (592)
Weight loss (183)
Date
Today (135)
Last 7 days (767)
Last 30 days (3652)
Last 365 days (35049)
2024 (32113)
2023 (39655)
2022 (50210)
2021 (54646)
2020 (52981)
2019 (46028)
2018 (34840)
2017 (30813)
2016 (29761)
2015 (34054)
2014 (25962)
2013 (21379)
2012 (22672)
2011 (23283)
2010 (20820)
Location
Africa (851)
Arizona (141)
Asia (36408)
Australia (6258)
California (3154)
Canada (1216)
China (246)
Colorado (140)
Connecticut (146)
Europe (83215)
Florida (432)
Georgia (118)
Illinois (311)
Indiana (178)
Kansas (91)
Maryland (551)
Massachusetts (2491)
Michigan (146)
Minnesota (254)
New Jersey (912)
New York (907)
North Carolina (711)
Northern California (1397)
Ohio (125)
Pennsylvania (783)
South America (1179)
Southern California (1256)
Texas (420)
Utah (87)
Washington State (347)
612,014 Results for "on target laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
Astellas’ First-in-Class, Claudin-Targeted Therapy Wins FDA Nod for Certain Gastric Cancers
The regulator’s approval on Friday of Vyloy for gastric or gastroesophageal junction cancer makes it the first and only claudin 18.2–targeted therapy approved in the U.S. for these indications, according to Astellas.
October 21, 2024
·
2 min read
·
Tristan Manalac
BioMidwest
On Target Laboratories Names Scott Huennekens as Executive Chairperson of the Board
On Target Laboratories, Inc. announced the appointment of Scott Huennekens as Executive Chairperson of the Board.
January 3, 2024
·
2 min read
CRISPR
CRISPR
Ex Vivo
Gene Editing Gets on Target With Caribou’s Hybrid Guides
While
ex vivo
genome editing results in highly effective cell therapies, it can lead to off-target effects. Caribou Biosciences has come up with a novel approach for potentially more precise gene editing compared to all-RNA guides.
October 14, 2024
·
5 min read
·
Greg Slabodkin
BioMidwest
On Target Laboratories Secures $30 Million for Commercialization of CYTALUX® (pafolacianine) injection
On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery, today announced the completion of a $30 million Series C financing.
November 16, 2023
·
5 min read
Biotech Beach
Kura Oncology to Participate in Stifel Targeted Oncology Forum
Kura Oncology, Inc. today announced its participation in Stifel 2024 Targeted Oncology Forum.
April 10, 2024
·
2 min read
Genetown
Compass Therapeutics to Participate in the Stifel Targeted Oncology Days
Compass Therapeutics, Inc. announced that the Company will participate in the Stifel Targeted Oncology Days taking place virtually April 16 – 17, 2024.
April 10, 2024
·
1 min read
Press Releases
Onchilles Pharma Presents New Preclinical Data for the Systemically Delivered NEU-002 Program Targeting the ELANE Pathway at SITC 2024
November 7, 2024
·
4 min read
News
Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics
October 9, 2024
·
4 min read
Deals
Lilly, Haya Ink Potential $1B Drug Discovery Deal to Target Obesity and Metabolic Conditions
Under a multi-year agreement announced Wednesday, Eli Lilly will leverage Haya Therapeutics’ proprietary RNA-guided genome platform to identify drug targets to address the chronic conditions.
September 4, 2024
·
2 min read
·
Kate Goodwin
Genetown
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,” “Company”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced that management will present a corporate overview at the Stifel 2024 Targeted Oncology Forum, taking place virtually from April 16-17, 2024.
April 10, 2024
·
3 min read
1 of 61,202
Next
